| To Evaluate Effect of Food of DA-5222 in Healthy Adult Subjects (NCT06993168) | Dong-A ST Co., Ltd. | 2025-05-21 |
| A Study Designed to Assess the Mass Balance Recovery, Absorption, Metabolism, Excretion of [14C]AZD5462 and the Absolute Bioavailability of AZD5462 (NCT06989983) | AstraZeneca | 2025-05-20 |
| Pilot Influenza Challenge Study (NCT07063849) | Daniel Hoft, MD, PhD | 2025-05-20 |
| A Pharmacokinetics and Safety Study of Azvudine Tablets in Subjects With Mild-To-Moderate GFR Decline in Renal Insufficiency and in Healthy Subjects (NCT07001436) | Henan Genuine Biotech Co., Ltd. | 2025-05-20 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GSK3862995B Administered as a Single Dose to Healthy Participants of Chinese, Japanese, and European Ancestry (NCT06979518) | GlaxoSmithKline | 2025-05-20 |
| A Phase I Study of SIM0686 in Participants With Locally Advanced/Metastatic Solid Tumors (NCT07050459) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2025-05-20 |
| Study of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors (NCT06938880) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2025-05-20 |
| A Study of Food Effect and Esomeprazole on LY4064809 in Healthy Adult Participants (NCT06991179) | Scorpion Therapeutics, a wholly owned subsidiary of Eli Lilly and Company | 2025-05-20 |
| A Study to Investigate the Effect of Food on Balcinrenone/Dapagliflozin Pharmacokinetics in Fed and Fasted State and Pharmacokinetics of Balcinrenone When Dosed With a P-gp Inhibitor in Healthy Participants. (NCT06979388) | AstraZeneca | 2025-05-20 |
| Effects of Carnosine In Patients With Peripheral Arterial Disease Patients (NCT06480760) | Shahid Baba | 2025-05-20 |
| Induction of Dreaming With EEG and Anesthesia in Healthy Adults (NCT07198711) | Stanford University | 2025-05-20 |
| Comparison of Inter-appointment Pain Reduction During Root Canal Treatment in Symptomatic Apical Periodontitis by Using Intracanal Medicaments; Chlorhexidine Gel and Single Antibiotic Paste Nitrofurantoin (NCT07198919) | Altamash Institute of Dental Medicine | 2025-05-20 |
| A Study in Healthy People to Test How 3 Different Formulations of BI 764198 Are Taken up in the Body and How This is Influenced by Food (NCT06955754) | Boehringer Ingelheim | 2025-05-20 |
| Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs. (NCT06975605) | GRIN Therapeutics, Inc. | 2025-05-20 |
| A Study on the Safety, Tolerability, Bioavailability and Mechanism of Action of Intravenous NAV-240 in Adults. (NCT06933043) | Navigator Medicines, Inc. | 2025-05-20 |
| Early Norepinephrine in Trauma Patients With Hemorrhagic Shock (NCT06977659) | Visarat Palitnonkiat | 2025-05-20 |
| A Long-term Study to Monitor the Health Status of People With Cystic Fibrosis Who Took Part in a Previous Study With BI 3720931 (Lenticlair™-ON) (NCT06962852) | Boehringer Ingelheim | 2025-05-20 |
| Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS (NCT06680752) | ARCE Therapeutics, Inc. | 2025-05-20 |
| A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Rheumatoid Arthritis (NCT06994143) | Cullinan Therapeutics Inc. | 2025-05-19 |
| ORKA-002-211 A Phase I Study to Evaluate ORKA-002 in Healthy Volunteers Following A Single Dose (NCT06944379) | Oruka Therapeutics, Inc. | 2025-05-19 |
| VR-based Physical Activity and Reminiscence Therapy (NCT06934720) | Hong Kong University of Science and Technology | 2025-05-19 |
| A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases (NCT06978647) | China Immunotech (Beijing) Biotechnology Co., Ltd. | 2025-05-19 |
| A Trial of SHR7280 in Healthy Subjects (NCT06969664) | Jiangsu HengRui Medicine Co., Ltd. | 2025-05-19 |
| Personalized Antisense Oligonucleotide Therapy for A Single Participant With ASXL3 Gene Mutation (NCT07197268) | n-Lorem Foundation | 2025-05-19 |
| To Evaluate the Effect of Food on the Pharmacokinetics of Y-4 Tablets in Healthy Subjects (NCT07013773) | Beijing Tiantan Hospital | 2025-05-19 |
| Vunakizumab for the Treatment of Mild to Moderate Systemic Lupus Erythematosus (NCT06881290) | Chinese SLE Treatment And Research Group | 2025-05-19 |
| Management of Skeletal Class III Malocclusion With Digital Bonded Reverse Twin Block in Mixed Dentition (NCT07376954) | Mansoura University | 2025-05-19 |
| The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration (NCT06319872) | University of Rochester | 2025-05-19 |
| SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET) (NCT06889493) | Peter Hosein, MD | 2025-05-19 |
| Pharmacokinetic Effect of Y-3 on Repaglinide，Warfarin and Omeprazole in Healthy Participants (NCT07068841) | Neurodawn Pharmaceutical Co., Ltd. | 2025-05-18 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABSK061 Mini-tablets in Healthy Adult Participants (NCT07007546) | Abbisko Therapeutics Co, Ltd | 2025-05-17 |
| A Phase I Clinical Study of a Single Dose of KLA480 (NCT07030790) | Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. | 2025-05-17 |
| Clinical Trial to Evaluate the Tolerance of TQB2210 Injection (NCT06929195) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2025-05-16 |
| Ph1, Randomized, Double-Blind and Controlled, Dose Escalation and Expansion Study to Assess the Safety and Pharmacokinetics of JST-010 in Healthy Adults (NCT06943378) | Just-Evotec Biologics | 2025-05-16 |
| Study of ZG005 in Combination With Gecacitinib in Patients With Relapsed or Refractory Lymphoma (NCT06883526) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2025-05-16 |
| A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes (NCT06945406) | Eli Lilly and Company | 2025-05-16 |
| A Study of SH009 Injection in Patients With Advanced Solid Tumors. (NCT07390838) | Nanjing Sanhome Pharmaceutical, Co., Ltd. | 2025-05-16 |
| HS-10542 Study in Healthy Participants (NCT07040046) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2025-05-16 |
| Evaluate the Safety and Pharmacokinetics/Pharmacodynamics and Food Effect of HS-20118 (NCT07033234) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2025-05-16 |
| A Study of Sotatercept (MK-7962) in Healthy Females Administered as a Liquid Formulation in an Autoinjector Versus the Lyophilized Formulation (MK-7962-027) (NCT06930664) | Merck Sharp & Dohme LLC | 2025-05-16 |
| Clinical Trial of Evaluating TQB3912 Tablets Combined With Fulvestrant Injection±TQB3616 Capsules for Locally Advanced or Metastatic Hormone Receptor(HR)-Positive and Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer (NCT06851442) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2025-05-16 |
| Effects of Omega-3 Fatty Acids on Acute Graft-versus-Host Disease After Allogeneic Stem Cell Transplantation. (NCT07162688) | Fujian Medical University | 2025-05-16 |
| A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine (NCT06995729) | Pfizer | 2025-05-16 |
| Evaluation of Locally Applied Ferulic Acid as Adjunct to Mechanical Debridement in Treatment of Periodontitis (NCT07404072) | Salah Awad Alanazi | 2025-05-16 |
| Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment (NCT07010692) | Bruce Robinson, MD | 2025-05-16 |
| Study of Tarlatamab in Combination With YL201 With or Without Anti-programmed Death Ligand 1 (PD-L1) in Participants With Extensive Stage (ES) Small Cell Lung Cancer (SCLC) (NCT06898957) | Amgen | 2025-05-16 |
| A Study of HS-10529 in KRAS G12D Patients With Advanced Solid Tumors (NCT06963398) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2025-05-15 |
| A Study of DXC008 in Patients With Prostate Cancer and Other Solid Tumors (NCT06926283) | Hangzhou DAC Biotechnology Co., Ltd. | 2025-05-15 |
| A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors (NCT06954077) | Sichuan Baili Pharmaceutical Co., Ltd. | 2025-05-15 |
| Preliminary Human Trials of F230 Tablets (NCT06899815) | Beijing Continent Pharmaceutical Co, Ltd. | 2025-05-15 |
| A Study on the Efficacy and Safety of Golidocitinib Combined With Tislelizumab and Chemotherapy as First-line Treatment for Advanced NSCLC (NCT06969612) | Peking University Cancer Hospital & Institute | 2025-05-15 |
| Stereotactic Intracerebral Injection of IPSC-DAPs in Patients with Parkinson's Disease (NCT06821529) | iCamuno Biotherapeutics Ltd. | 2025-05-15 |
| Impact of Nutritional Supplementation on Sleep Quality (NCT06935123) | Pharmavite LLC | 2025-05-15 |
| A New Treatment of Newly Diagnosed KIT Mutation CBF-Acute Myeloid Leukemia (NCT07028073) | The First Affiliated Hospital of Soochow University | 2025-05-15 |
| Research on the Application of 68Ga-PSMA-CYC PET Imaging in the Diagnosis, Staging, and Restaging of Prostate Cancer (NCT07056790) | First Affiliated Hospital of Fujian Medical University | 2025-05-15 |
| Intraosseous (IO) Cefazolin and Vancomycin in Primary Total Knee Arthroplasty (TKA) (NCT06640491) | The Methodist Hospital Research Institute | 2025-05-15 |
| A Study of the Pharmacokinetics and Safety of Single-dose Inhaled RJ026 in Healthy Volunteers and Patients With Interstitial Lung Disease (NCT06992661) | Ruijin Hospital | 2025-05-15 |
| A Drug-drug Interaction Study to Investigate the Pharmacokinetic Interactions Between CKD-508, Midazolam, and Rosuvastatin in Healthy Adult Male Participants (NCT06979973) | Chong Kun Dang Pharmaceutical | 2025-05-14 |
| SLV-154 Treatment of Advanced Cancers (NCT06771219) | Solve Therapeutics | 2025-05-14 |
| ENA-001 for Opioid Induced Respiratory Depression (NCT06967259) | Enalare Therapeutics Inc. | 2025-05-14 |
| A Multicenter, Open-label, Non-randomized Phase I/IIa Clinical Trial to Evaluate INR102 Injection in Patients With Prostate Cancer (NCT06970119) | Yunhe Pharmaceutical (Tianjin) Co., Ltd | 2025-05-14 |
| Drug-Drug Interaction of Rifampicin and Cyclosporine on Methotrexate Pharmacokinetics in Healthy Subjects (NCT07196449) | Seoul National University Bundang Hospital | 2025-05-14 |
| First-In-Human Study to Evaluate Single and Multiple Ascending Doses of JUV-161 in Healthy Adult Volunteers (NCT06918925) | Juvena Therapeutics | 2025-05-14 |
| A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab Alone (NCT06806852) | Boehringer Ingelheim | 2025-05-14 |
| A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Healthy and Asthmatic Participants (NCT06947408) | Innovent Biologics (Suzhou) Co. Ltd. | 2025-05-14 |
| A Phase 1 Trial of Intranasal Mumps Virus Vaccines in Healthy Adults (NCT06967181) | CyanVac LLC | 2025-05-14 |
| The Phase 1b/IIa, Open-label, Dose Escalation and Dose Expansion to Evaluate Safety, Tolerability, and Preliminary Efficacy of the Combination of HCB101, Cetuximab/Bevacizumab, and FOLFOX/FOLFIRI in Advanced or Metastatic Colorectal Cancer (NCT07204574) | Chang Gung Memorial Hospital | 2025-05-14 |
| Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cell Therapy in Patients With MDR-SRNS (NCT06842589) | The Children's Hospital of Zhejiang University School of Medicine | 2025-05-14 |
| Study of GS-0151 in Participants With Rheumatoid Arthritis (NCT06902519) | Gilead Sciences | 2025-05-14 |
| A Study of Andecaliximab in People With Spinal Cord Injury at Risk for Bone Growth Outside of the Normal Skeleton. (NCT07024407) | Ashibio Inc | 2025-05-14 |
| Phase 1 Study of M9466 Combined With Carboplatin and Platinum-based Anticancer Therapy (DDRiver 521) (NCT06719973) | EMD Serono Research & Development Institute, Inc. | 2025-05-14 |
| A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease (NCT06858397) | GC Biopharma Corp | 2025-05-14 |
| A Single- and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY4066708 in Healthy Participants (NCT07046559) | Eli Lilly and Company | 2025-05-13 |
| STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer (NCT06574880) | Angela Y. Jia, MD PhD | 2025-05-13 |
| A Study to Evaluate Opevesostat (MK-5684) in Male Participants With Moderate Hepatic Impairment (MK-5684-009) (NCT06860243) | Merck Sharp & Dohme LLC | 2025-05-13 |
| Phase 1 Study on Bioavailability, Food Effect, and Drug-Drug Interaction of ALG-097558 Tablets in Healthy Volunteers (NCT06945276) | National Institute of Allergy and Infectious Diseases (NIAID) | 2025-05-13 |
| Treatment of Charcot-Marie-Tooth Disease, Axonal, Type 2S (CMT2S) in an Individual Patient (NCT07223632) | Vanda Pharmaceuticals | 2025-05-13 |
| A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A. (NCT06703606) | Pfizer | 2025-05-13 |
| A Study to Evaluate the the Bioequivalence of Two Different Pimicotinib Capsules in Healthy Subjects (NCT07126249) | Abbisko Therapeutics Co, Ltd | 2025-05-13 |
| A Multinational Study Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN1) (NCT06905197) | Dizal Pharmaceuticals | 2025-05-13 |
| Pharmacokinetics (PK) and Safety of Zanzalintinib in Participants With Moderate Hepatic Impairment (HI) (NCT06962332) | Exelixis | 2025-05-13 |
| A Study of Nimotuzumab Plus Adebrelimab With Chemotherapy in Cisplatin-Ineligible Patients With Head And Neck Squamous Cell Carcinoma (NCT07105592) | Fudan University | 2025-05-13 |
| A Study to Evaluate the Effect of Formulation and Food on Calderasib (MK-1084) in Healthy Adult Participants (MK-1084-011) (NCT06942741) | Merck Sharp & Dohme LLC | 2025-05-13 |
| A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1 (NCT06961266) | Jazz Pharmaceuticals | 2025-05-13 |
| Pomalidomide as an Immune-enhancing Agent for the Control of HIV (NCT06660498) | University of Aarhus | 2025-05-13 |
| Paclitaxel Cationic Liposome (Hepatic Arterial Infusion) in Combination With Systemic Therapy as First-Line Treatment in Colorectal Liver Metastases (NCT07117435) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2025-05-13 |
| A Study Evaluating the Pharmacokinetics, Safety, and Efficacy of Cevostamab in Chinese Participants With Relapsed or Refractory Multiple Myeloma (NCT06934044) | Hoffmann-La Roche | 2025-05-13 |
| Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer (NCT06736379) | VLP Therapeutics | 2025-05-13 |
| A Study of ZL-1310 in Participants With Selected Solid Tumors (NCT06885281) | Zai Lab (Shanghai) Co., Ltd. | 2025-05-12 |
| The Effect of Local Infiltration of Tranexamic Acid on Postoperative Blood Loss in Orthognathic Surgery (NCT06983886) | Ramathibodi Hospital | 2025-05-12 |
| CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D) (NCT06783309) | COUR Pharmaceutical Development Company, Inc. | 2025-05-12 |
| Drug-Drug Interaction and Food Effect of Sudapyridine(WX-081) With Itraconazole and Rifampin in Healthy Chinese Adults (NCT06701136) | Shanghai Jiatan Pharmatech Co., Ltd | 2025-05-12 |
| A Study to Investigate the Pharmacokinetics of AZD2389 in Healthy Participants When Administered Alone and in Combination With Quinidine (NCT06974565) | AstraZeneca | 2025-05-12 |
| A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in Healthy Subjects and Patients With Immune Thrombocytopenia (ITP) (NCT06929299) | Jiangsu BioJeTay Biotechnology Co., Ltd. | 2025-05-12 |
| Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer (NCT06801236) | Acerand Therapeutics (Hong Kong) Limited | 2025-05-12 |
| Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed Advanced NSCLC and Positive PD-L1 (NCT06579196) | University of Nebraska | 2025-05-12 |
| MT027 in Patients With Advanced Peritoneal Malignancies or Abdominal Metastatic Solid Tumors (NCT06912152) | Zhejiang University | 2025-05-12 |
| A Study to Evaluate the Relative Bioavailability of New Formulations of INCB057643 Tablets Administered Orally in Healthy Participants (NCT06941077) | Incyte Corporation | 2025-05-12 |
| Phase I Study of BC008-1A Injection in Patients With Advanced Solid Tumors (NCT06773507) | Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd. | 2025-05-12 |
| Pharmacokinetics and Bioequivalence Study of Empagliflozin+Metformin Hydrochloride 12.5 mg/1000 mg Film-coated Tablets (Gedeon Richter Plc., Hungary) Versus Synjardy 12.5 mg/1000 mg Film-coated Tablets (Boehringer Ingelheim International GmbH, Germany) (NCT06823856) | Gedeon Richter Plc. | 2025-05-11 |